Have Insiders Sold AdaptHealth Shares Recently?

Anyone interested in AdaptHealth Corp. (NASDAQ:AHCO) should probably be aware that a company insider, Shaw Rietkerk, recently divested US$281k worth of shares in the company, at an average price of US$11.24 each. That sale was 11% of their holding, so it does make us raise an eyebrow.

Check out our latest analysis for AdaptHealth

The Last 12 Months Of Insider Transactions At AdaptHealth

Notably, that recent sale by Shaw Rietkerk is the biggest insider sale of AdaptHealth shares that we've seen in the last year. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. The silver lining is that this sell-down took place above the latest price (US$10.19). So it is hard to draw any strong conclusion from it.

Insiders in AdaptHealth didn't buy any shares in the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

I will like AdaptHealth better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.

Insider Ownership

Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. It's great to see that AdaptHealth insiders own 11% of the company, worth about US$156m. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

So What Does This Data Suggest About AdaptHealth Insiders?

Insiders sold AdaptHealth shares recently, but they didn't buy any. Looking to the last twelve months, our data doesn't show any insider buying. It is good to see high insider ownership, but the insider selling leaves us cautious. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. For example - AdaptHealth has 1 warning sign we think you should be aware of.

Of course AdaptHealth may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.